The call, open until 18 February, is part of the 2025 EP PerMed grants, financed by the Government of Navarra’s own funds and the European

As a novelty this year, the International Plan of Navarra prepared an interactive virtual catalogue for this event, which included, on the one hand, the

The facility, known as Nave Neo and developed with 4.0 technology, has involved a total investment of approximately 40 million euros. Thanks to this new

The event, organised by Navarra Health Cluster (NHC) and ADItech, brought together representatives from 11 entities of the Navarra R&D&I System (SINAI), as well as

The Finnish multinational will use the active substance and the pharmaceutical product provided by 3PBIOVIAN to develop a mucosal immune response in nasopharyngeal cells. These

The NAGENdata project is a personalised medicine initiative, financed by the Government of Navarra, with the aim of promoting the health of citizens as well

3P Biopharmaceuticals and Biovan, two leading biotechnology and Contract Development and Manufacturing (CDMO) organisations, are behind this initiative. They aim to further expand their value

The call, called EP-PerMed, will run for the next 7 years. In each of these years, proposals may be submitted for funding of up to

The sector, which has more than 80 companies and employs 31,000 people in the Autonomous Community of Navarre, has increased its turnover by 23% since

The medicines distributor, which currently serves 525 of the 600 pharmacies in Navarre, has doubled its turnover in recent years. It has gone from a